Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Diamantstein

Showing results (91-100 of 243) with videos related to

Pageof 25
Sort By:
International Archives of Allergy and Applied Immunology|January 1, 1982
Chitin: an immunological adjuvant and a polyclonal B-lymphocyte activatorT Diamantstein, M Klos, H Osawa, et al.
International Archives of Allergy and Applied Immunology|January 1, 1976
Differences between lymphoid cell populations of guinea pigs and mice as determined by the response to mitogens in vitroS Ben-Efraim, A Ulmer, M Schmidt, et al.
Arzneimittel-Forschung|December 1, 1991
[Immunorestitutive action of hydrolysates and ultrafiltrates of bovine spleen]H D Volk, R Eckert, T Diamantstein, et al.
European Journal of Immunology|April 1, 1990
Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicityT Blankenstein, W Q Li, W Müller, et al.
Molecular Immunology|November 1, 1986
Regulation of interleukin-2 receptor expression and receptor releaseT Diamantstein, H Osawa, A Mouzaki, et al.
European Journal of Immunology|March 1, 1987
Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18A Mouzaki, H D Volk, H Osawa, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Production of cytokines by human melanoma cells and melanocytesS Krüger-Krasagakes, K Krasagakis, C Garbe, et al.
European Journal of Immunology|October 1, 1986
Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptorH D Volk, S Brocke, H Osawa, et al.
Immunology|March 1, 1989
Demonstration of two distinct forms of released low affinity-type rat IL-2 receptorsT Herrmann, O Josimovic-Alasevic, A Mouzaki, et al.
Transplantation Proceedings|February 1, 1989
Appearance of ART-18-positive (IL-2R) cells in peripheral blood and spleen after donor-specific blood transfusion (DST) in rats differing across the major histocompatibility complexB Wasowska, T Ryffa, W L Olszewski, et al.
Pageof 25

Showing results (91-100 of 243) with videos related to

Sort By:
Pageof 25
International Archives of Allergy and Applied Immunology|January 1, 1982
Chitin: an immunological adjuvant and a polyclonal B-lymphocyte activatorT Diamantstein, M Klos, H Osawa, et al.
International Archives of Allergy and Applied Immunology|January 1, 1976
Differences between lymphoid cell populations of guinea pigs and mice as determined by the response to mitogens in vitroS Ben-Efraim, A Ulmer, M Schmidt, et al.
Arzneimittel-Forschung|December 1, 1991
[Immunorestitutive action of hydrolysates and ultrafiltrates of bovine spleen]H D Volk, R Eckert, T Diamantstein, et al.
European Journal of Immunology|April 1, 1990
Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicityT Blankenstein, W Q Li, W Müller, et al.
Molecular Immunology|November 1, 1986
Regulation of interleukin-2 receptor expression and receptor releaseT Diamantstein, H Osawa, A Mouzaki, et al.
European Journal of Immunology|March 1, 1987
Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18A Mouzaki, H D Volk, H Osawa, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1995
Production of cytokines by human melanoma cells and melanocytesS Krüger-Krasagakes, K Krasagakis, C Garbe, et al.
European Journal of Immunology|October 1, 1986
Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptorH D Volk, S Brocke, H Osawa, et al.
Immunology|March 1, 1989
Demonstration of two distinct forms of released low affinity-type rat IL-2 receptorsT Herrmann, O Josimovic-Alasevic, A Mouzaki, et al.
Transplantation Proceedings|February 1, 1989
Appearance of ART-18-positive (IL-2R) cells in peripheral blood and spleen after donor-specific blood transfusion (DST) in rats differing across the major histocompatibility complexB Wasowska, T Ryffa, W L Olszewski, et al.
Pageof 25